GT Biopharma, Inc.

GT Biopharma, Inc. Estimates – NASDAQ:GTBP
TradingView · 23 Oct 2026
GT Biopharma, Inc. SEC Filing (Oct 21, 2026) | GTBP EFFECT
Stock Titan · 21 Oct 2026
Form 4 GT Biopharma Inc For: 20 October By Investing.com
Investing.com Canada · 21 Oct 2026
GT Biopharma proposes 250 million shares and dilution risk rises for GT Biopharma stock
AD HOC NEWS · 15 Oct 2026
Form S-1 GT Biopharma Inc For: 9 October By Investing.com
Investing.com India · 10 Oct 2026
Gt Biopharma Selling Stockholders To Offer Up To 13,502,835 Shares Of Common Stock
TradingView · 09 Oct 2026
GT Biopharma Regains Nasdaq Minimum Bid Compliance
The Globe and Mail · 26 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.